Skip to content

Author

Mahmoud M. Khattab

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Involvement of JAK2/STAT3, PI3K/AKT/mTOR, and M1/M2 microglial polarization in the possible effects of baricitinib for mitigating reserpine-induced fibromyalgia in rats.

Fibromyalgia (FM) is a chronic pain disorder characterized by widespread musculoskeletal pain accompanied by fatigue, mood disturbances, and sleep abnormalities. Baricitinib, a selective Janus kinase (JAK) 1/2 inhibitor, has potent anti-inflammatory and immunomodulatory effects and is approved for various resistant inf...

Ibrahim M. Alfoud, Aya M. Abd El-latif, Weam W. Ibrahim et al. · 0 citations
Aug 2026

Baricitinib ameliorates behavioral deficits and NLRP3-related neuroinflammation in a ketamine rat model of schizophrenia: Role of JAK2/STAT3 and PI3K/AKT/mTOR signaling.

It is indicated that baricitinib exerts robust neuroprotective effects in a ketamine model of schizophrenia, accompanied by attenuation of neuroinflammation and modulation of the JAK/STAT and PI3K/AKT/mTOR pathways.

Ali A Albariqi, Dalia A. Nawwar, Weam W. Ibrahim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.